Hyderabad Telangana, India

Sunil Kumar Singh


 

Average Co-Inventor Count = 3.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2007-2017

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Sunil Kumar Singh: A Pioneer in Dipeptidylpeptidase Inhibitors

Introduction: Sunil Kumar Singh, based in Hyderabad, Telangana, India, is a notable inventor who has made significant contributions to the field of pharmaceutical chemistry. With three patents to his name, Singh has focused on innovative processes that enhance the preparation of therapeutic compounds, particularly dipeptidylpeptidase inhibitors.

Latest Patents: Among his latest inventions, Singh has developed a groundbreaking process for the preparation of linagliptin, a compound of Formula I. This process involves deprotecting a specific compound of Formula II, wherein R and R together with the nitrogen to which they are attached form a phthalimido group. The aromatic ring of the phthalimido group is modified with substituents chosen from a diverse group including halogen, alkyl, nitro, and amino. Additional substitutions of R and R are explored, facilitating a range of functional groups such as trialkylsilyl and sulfonyl variations. This innovation represents a significant advancement in the creation of effective inhibitors, contributing to the treatment of conditions such as diabetes.

Career Highlights: Sunil Kumar Singh has garnered experience in reputable organizations including Glenmark Pharmaceuticals Limited and Dr. Reddy's Laboratories Incorporated. His tenure at these companies has equipped him with the expertise necessary to drive innovations in pharmaceutical development.

Collaborations: Throughout his career, Singh has collaborated with talented professionals, including Sachin Srivastava and Shekhar Bhaskar Bhirud. These partnerships have likely fostered a productive environment conducive to pioneering research and development in the industry.

Conclusion: With his innovative spirit and dedication to advancing pharmaceutical sciences, Sunil Kumar Singh continues to play an essential role in the development of dipeptidylpeptidase inhibitors. His inventions not only contribute to scientific knowledge but also hold the potential to improve healthcare outcomes for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…